Outcomes of surveillance for contralateral breast cancer in patients less than age 60 at the time of initial diagnosis

Current Oncology

Volumn 19, Issue 3, 2012, Pages

  Weinstock, C ^a,b   Bigenwald, R ^a   Hochman, T ^c   Sun, P ^d   Narod, S A ^d   Warner, Ellen ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Contralateral cancer; Detection; Mammography; Surveillance

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER STAGING; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAMMOGRAPHY; ONSET AGE; OUTCOME ASSESSMENT; PRIMARY TUMOR; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS;

EID: 84930482702     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.19.890     Document Type: Article

References (29)

1. Chen Y, Thompson W, Semenciw R, Mao Y. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:855-61.
2. Vuoto HD, García AM, Candás GB, et al. Bilateral breast carcinoma: clinical characteristics and its impact on survival. Breast J 2010;16:625-32.
3. National Comprehensive Cancer Network (nccn). Breast Cancer. NCCN Practice Guidelines in Oncology. Ver. 2.2011. Fort Washington, PA: nccn; 2011: binv-16.
4. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L on behalf of the U.S. Preventive Services Task Force. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:727-37, W237-42.
5. Wolfe JN. Breast parenchymal patterns and their changes with age. Radiology 1976;121:545-52.
6. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003;138:168-75.
7. Peer PG, van Dijck JA, Hendriks JH, Holland R, Verbeek AL. Age-dependent growth rate of primary breast cancer. Cancer 1993;71:3547-51.
8. Porter PL, El-Bastawissi AY, Mandelson MT, et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval-and screen-detected cancers. J Natl Cancer Inst 1999;91:2020-8.
9. Gilliland FD, Joste N, Stauber PM, et al. Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst 1999;91:2020-8.
10. Brekelmans CT, van Gorp JM, Peeters PH, Collette HJ. Histopathology and growth rate of interval breast carcinoma. Characterization of different subgroups. Cancer 1996;78:1220-8.
11. Houssami N, Ciatto S, Martinelli F, Bonardi R, Duffy SW. Early detection of second breast cancers improves prognosis in breast cancer survivors. Ann Oncol 2009;20:1505-10.
12. Sawka CA, Pritchard KI, Lickley HL, et al. The Henrietta Banting Breast Centre database: a model for clinical research utilizing a hospital-based inception cohort. J Clin Epidemiol 1995;48:779-86.
13. Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007;13:4429-34.
14. Orel SG, Troupin RH, Patterson EA, Fowble BL. Breast cancer recurrence after lumpectomy and irradiation: role of mammography in detection. Radiology 1992;183:201-6.
15. Grosse A, Schreer I, Frischbier HJ, Maass H, Loening T, Bahnsen J. Results of breast conserving therapy for early breast cancer and the role of mammographic follow-up. Int J Radiat Oncol Biol Phys 1997;38:761-7.
16. Ashkanani F, Sarkar T, Needham G, et al. What is achieved by mammographic surveillance after breast conservation treatment for breast cancer? Am J Surg 2001;182:207-10.
17. Joseph E, Hyacinthe M, Lyman GH, et al. Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer. Ann Surg Oncol 1998;5:522-8.
18. de la Rochefordière A, Mouret-Fourme E, Asselain B, et al. Metachronous contralateral breast cancer as first event of relapse. Int J Radiat Oncol Biol Phys 1996;36:615-21.
19. Kollias J, Evans AJ, Wilson AR, Ellis IO, Elston CW, Blamey RW. Value of contralateral surveillance mammography for primary breast cancer follow-up. World J Surg 2000;24:983-7.
20. Hill-Kayser CE, Harris EE, Hwang WT, Solin LJ. Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation. Int J Radiat Oncol Biol Phys 2006;66:1313-19.
21. Robinson A, Speers C, Olivotto I, Chia S. Method of detection of new contralateral primary breast cancer in younger versus older women. Clin Breast Cancer 2007;7:705-9.
22. Autier P, Héry C, Haukka J, Boniol M, Byrnes G. Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. J Clin Oncol 2009;27:5919-23.
23. Lakhani SR, Jacquemier J, Sloane JP, et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 1998;90:1138-45.
24. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995;57:1457-62.
25. D'Orsi CJ, Newell MS. Digital mammography: clinical implementation and clinical trials. Semin Roentgenol 2007;42:236-42.
26. Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008;299:2151-63.
27. Bernard JR Jr, Vallow LA, DePeri ER, et al. In newly diagnosed breast cancer, screening mri of the contralateral breast detects mammographically occult cancer, even in elderly women: the Mayo Clinic in Florida experience. Breast J 2010;16:118-26.
28. Lehman CD, Gatsonis C, Kuhl CK, et al. mri evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007;356:1295-303.
29. Tsoi D, Holloway C, Bordeleau L, Brezden-Masley C, Causer P, Warner E. Willingness of breast cancer survivors to participate in a randomized study of digital mammography with or without mri as breast cancer surveillance: a feasibility study. Breast 2011;20:96-8.